Autor: |
Saffarzadeh, Areo G., Canavan, Maureen, Resio, Benjamin J., Walters, Samantha L., Flores, Kaitlin M., Decker, Roy H., Boffa, Daniel J. |
Zdroj: |
JTO Clinical and Research Reports; 20210101, Issue: Preprints |
Abstrakt: |
There are currently two recommended radiation strategies for clinical stage III non-small cell lung cancer (NSCLC); a lower “preoperative” (45-54 Gy) and a higher “definitive/non-surgical” (60-70 Gy) dose. We sought to determine if definitive radiation doses should be used in the preoperative setting, given that many clinical stage III patients planned for surgery are ultimately managed with chemoradiation alone. |
Databáze: |
Supplemental Index |
Externí odkaz: |
|